Who owns SALARIUS PHARMACEUTICALS INC?
- Ticker: SLRX
- CUSIP Number: 79400x404
Tip: Access positions for across all investors
Analyze quarterly positions in Salarius Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Salarius Pharmaceuticals stock
Who bought or sold SALARIUS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Advisor Group Holdings | 59.00 | $32.998700 | 0% | Sep 2025 |
|
| Morgan Stanley | 7.00 | $5.999700 | 100% | Jun 2025 |
|
Who sold out of Salarius Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hrt Financial | Jun 2025 | 32k | $28k |
| UBS Group | Jun 2025 | 18k | $18k |
| Cubist Systematic Strategies | Jun 2025 | 17k | $15k |
| Geode Capital Management | Jun 2025 | 16k | $14k |
| Barclays | Jun 2025 | 8.0k | $7.0k |
| Tower Research Capital | Jun 2025 | 3.7k | $3.3k |
| Mount Yale Investment Advisors | Jun 2025 | 61.00 | $54.997600 |